Rating History for Bicara Therapeutics Inc (BCAX) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for BCAX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/11/2026 Richard Law Downgrade Neutral
(Buy)		 14.00
(N/A)		 14.97
(18.47)		 23.38% Details